- Home
- NKTX vs HLP Comparison
NKTX vs HLP Comparison
Compare NKTX & HLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- HLP
- Stock Information
- Founded
- NKTX 2015
- HLP 2021
- Country
- NKTX United States
- HLP China
- Employees
- NKTX N/A
- HLP 167
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- HLP Industrial Machinery/Components
- Sector
- NKTX Health Care
- HLP Industrials
- Exchange
- NKTX Nasdaq
- HLP Nasdaq
- Market Cap
- NKTX 123.5M
- HLP 98.8M
- IPO Year
- NKTX 2020
- HLP 2023
- Fundamental
- Price
- NKTX $2.06
- HLP $1.36
- Analyst Decision
- NKTX Strong Buy
- HLP
- Analyst Count
- NKTX 5
- HLP 0
- Target Price
- NKTX $13.50
- HLP N/A
- AVG Volume (30 Days)
- NKTX 773.5K
- HLP 183.4K
- Earning Date
- NKTX 11-06-2025
- HLP 09-19-2025
- Dividend Yield
- NKTX N/A
- HLP N/A
- EPS Growth
- NKTX N/A
- HLP N/A
- EPS
- NKTX N/A
- HLP 0.02
- Revenue
- NKTX N/A
- HLP $16,731,357.00
- Revenue This Year
- NKTX N/A
- HLP N/A
- Revenue Next Year
- NKTX N/A
- HLP N/A
- P/E Ratio
- NKTX N/A
- HLP $63.70
- Revenue Growth
- NKTX N/A
- HLP 19.13
- 52 Week Low
- NKTX $1.31
- HLP $0.61
- 52 Week High
- NKTX $4.55
- HLP $1.82
- Technical
- Relative Strength Index (RSI)
- NKTX 46.37
- HLP 77.12
- Support Level
- NKTX $2.10
- HLP $1.14
- Resistance Level
- NKTX $2.24
- HLP $1.54
- Average True Range (ATR)
- NKTX 0.10
- HLP 0.14
- MACD
- NKTX 0.01
- HLP 0.03
- Stochastic Oscillator
- NKTX 39.39
- HLP 88.13
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About HLP Hongli Group Inc.
Hongli Group Inc is a cold roll-formed steel profile manufacturer in China. It customizes and manufactures cold roll-formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation. Geographically, the company generates the majority of its revenue from the PRC.